Top list · Cambridge
29 pharma startups in Cambridge have raised money in rounds we track. These are the 29 that have raised the most, $3.0B between them.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Founded -Cambridge, United States$280Mlast round Apr 2024Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$220Mlast round Oct 2026Aera Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$193Mlast round Feb 2023Infinity alumni page
Founded 2001Cambridge, United States$181Mlast round Oct 2012Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Founded 2012Cambridge, United States$167Mlast round Mar 2026Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Founded 2020Cambridge, United States$150Mlast round Feb 2026ConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.
Founded 2018Cambridge, United States$150Mlast round Mar 2022Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Founded 2020Cambridge, United States$130Mlast round Jun 2024KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
Founded 2011Cambridge, United States$125Mlast round Sept 2025Flare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.
Founded 2021Cambridge, United States$123Mlast round Mar 2023Stipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.
Founded 2022Cambridge, United States$100Mlast round Apr 2026Be Biopharma, also known as Be Bio, is a clinical-stage biotechnology company based in Cambridge, Massachusetts.
Founded 2020Cambridge, United States$92Mlast round Jan 2025Satellite Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2019.
Founded 2019Cambridge, United States$83Mlast round Mar 2022Sirtris, a GSK company, is developing small molecule drugs that target the sirtuins.
Founded 2004Cambridge, United States$82Mlast round Apr 2006Zag Bio is a biotechnology company based in Cambridge, Massachusetts, focused on developing thymus-targeted medicines to treat and prevent autoimmune diseases.
Founded 2022Cambridge, United States$80Mlast round Oct 2025Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.
Founded 2014Cambridge, United States$76Mlast round Jul 2026Targanta Therapeutics is a biopharma Company
Founded 2005Cambridge, United States$70Mlast round Feb 2007Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
Founded -Cambridge, United States$56Mlast round Sept 2026Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms.
Founded 2011Cambridge, United States$52Mlast round Nov 2024Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Founded 2015Cambridge, United States$50Mlast round Jan 2026Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Founded -Cambridge, United States$38Mlast round Jan 2026Nabla Bio is a biotechnology company founded in 2020 that focuses on developing selective and functional drugs for previously undruggable targets, such as GPCRs
Founded 2020Cambridge, United States$37Mlast round May 2024CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Founded 2016Cambridge, United States$30Mlast round Dec 2025Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Founded 2015Cambridge, United States$28Mlast round Jul 2024Navitor Pharmaceuticals is an early-stage biopharmaceutical company co-founded by David Sabatini.
Founded 2010Cambridge, United States$24Mlast round Jun 2014Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Founded 2013Cambridge, United States$21Mlast round Aug 2024Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.
Founded 2020Cambridge, United States$19Mlast round Dec 2021Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Founded 2010Cambridge, United States$3.6Mlast round Oct 2025Companies whose funding rounds we classed in this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back pharma startups in Cambridge in the app, with filters, lists and exports.
ALNR
RBPharma startups in the United States540 companies · $23BNR
DT
VPharma startups that raised in 2026198 companies · $10B in 2026
C
OT
APharma startups in the United Kingdom76 companies · $4.0B
DT
QPPharma startups founded in 201963 companies · $3.5B
AL
RB
MTPharma startups founded in 202160 companies · $6.3B
I
MT
8Pharma startups founded in 201858 companies · $4.5BNR
BTPharma startups founded in 202057 companies · $3.5B
IP
IT
VTPharma startups in France40 companies · $803M
BM
E
RTStartups in Cambridge456 companies · $19B
BM
E
RTBiotech startups in Cambridge183 companies · $16B
RT
TT
KTHealthcare startups in Cambridge85 companies · $9.2B
S
LS
WRAI startups in Cambridge51 companies · $3.4B
T
AT
CIT Services startups in Cambridge33 companies · $244M
T
K
TBig Data & Analytics startups in Cambridge23 companies · $688M
IS
T
DLSoftware startups in Cambridge10 companies · $511M